Search research articles
Contact Us
Filters
Showing results (61-70 of 113) with videos related to
Page
of 12
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1976
Macrophage killing capacity. Aspects of mechanism
R Gallily, H Eliahu, Z Ben-Ishay
Biochimica Et Biophysica Acta
|
March 19, 1976
Motion of spin-labeled fatty acids in murine macrophages. Relation to cellular phagocytic activity
A J Schroit, S Rottem, R Gallily
Cancer Immunology, Immunotherapy : CII
|
January 1, 1986
Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts
R Gallily, G E Gifford, J Loewenstein
Immunopharmacology
|
September 1, 1981
Mouse macrophage functions under the influence of factors released by spleen cells preincubated with the methanol extraction residue (MER) tubercle bacillus fraction
R Gallily, I Stain, D W Weiss
European Journal of Immunology
|
June 1, 1973
The capacity of macrophage components to inhibit anti-macrophage serum activity
A J Schroit, B Geiger, R Gallily
Advances in Experimental Medicine and Biology
|
January 1, 1976
Potentiated lysosomal enzyme, bacteriostatic and bactericidal activities of peritoneal macrophages of mice treated with MER fraction of tubercle bacilli
R Gallily, S Yagel, D W Weiss
Infection and Immunity
|
November 1, 1977
Potentiation of mouse peritoneal macrophage antibacterial functions by treatment of the donor animals with the methanol extraction residue fraction of tubercle bacilli
R Gallily, Z Douchan, D W Weiss
Journal of the Reticuloendothelial Society
|
December 1, 1981
Development of alveolar macrophages in specific pathogen-free and germ-free Minnesota miniature swine
R Rothlein, R Gallily, Y B Kim
Cellular Immunology
|
October 1, 1975
Effect of treatment with the MER fraction of tubercle bacilli on hydrolytic lysosomal enzyme activity of mouse peritoneal macrophages
S Yagel, R Gallily, D W Weiss
Medical Hypotheses
|
January 1, 1981
Enhanced polymorphonuclear chemotaxis - a common feature of diseases responsive to colchicine
M Levy, M Ehrenfeld, R Gallily, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 113) with videos related to
Sort By:
Page
of 12
Advances in Experimental Medicine and Biology
|
January 1, 1976
Macrophage killing capacity. Aspects of mechanism
R Gallily, H Eliahu, Z Ben-Ishay
Biochimica Et Biophysica Acta
|
March 19, 1976
Motion of spin-labeled fatty acids in murine macrophages. Relation to cellular phagocytic activity
A J Schroit, S Rottem, R Gallily
Cancer Immunology, Immunotherapy : CII
|
January 1, 1986
Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts
R Gallily, G E Gifford, J Loewenstein
Immunopharmacology
|
September 1, 1981
Mouse macrophage functions under the influence of factors released by spleen cells preincubated with the methanol extraction residue (MER) tubercle bacillus fraction
R Gallily, I Stain, D W Weiss
European Journal of Immunology
|
June 1, 1973
The capacity of macrophage components to inhibit anti-macrophage serum activity
A J Schroit, B Geiger, R Gallily
Advances in Experimental Medicine and Biology
|
January 1, 1976
Potentiated lysosomal enzyme, bacteriostatic and bactericidal activities of peritoneal macrophages of mice treated with MER fraction of tubercle bacilli
R Gallily, S Yagel, D W Weiss
Infection and Immunity
|
November 1, 1977
Potentiation of mouse peritoneal macrophage antibacterial functions by treatment of the donor animals with the methanol extraction residue fraction of tubercle bacilli
R Gallily, Z Douchan, D W Weiss
Journal of the Reticuloendothelial Society
|
December 1, 1981
Development of alveolar macrophages in specific pathogen-free and germ-free Minnesota miniature swine
R Rothlein, R Gallily, Y B Kim
Cellular Immunology
|
October 1, 1975
Effect of treatment with the MER fraction of tubercle bacilli on hydrolytic lysosomal enzyme activity of mouse peritoneal macrophages
S Yagel, R Gallily, D W Weiss
Medical Hypotheses
|
January 1, 1981
Enhanced polymorphonuclear chemotaxis - a common feature of diseases responsive to colchicine
M Levy, M Ehrenfeld, R Gallily, et al.
Page
of 12